Non Interventional German Leptomeningeal Disease Register
Deutsches Meningeosis Neoplastica Register
University Hospital Tuebingen
50 participants
Jun 26, 2024
OBSERVATIONAL
Conditions
Summary
The planned multicenter register is intended to create a database in the form of a cancer register on the incidence and course of disease in Germany of leptomeningeal disease, the therapeutic measures administered in the real world and the complications.
Eligibility
Inclusion Criteria4
- Patients with leptomeningeal disease
- Written consent of the patient or legal guardian.
- Capacity to give consent or legal guardianship
- Age ≥ 18 years
Exclusion Criteria3
- Lack of informed consent from the patient
- Lack of capacity to consent on the part of the person concerned or lack of legal guardianship
- Age < 18 years
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Once the patient or their legal guardian has given their written consent, a patient is included in the leptomeningeal disease register. Due to the rapid course of the disease and potential rapid deterioration, the documentation of the course of the disease of the individual patients is to be carried out retrospectively from the data recorded during the course of the clinical routine for the entire duration of the study or until the death of the participating patients after the written consent of the patients. The registry's data sources are the diagnostic findings made at the center and doctors' letters from routine clinical practice. The participating centers carry out the assessment of the participants' performance status so that the patients do not have to complete any study-related questionnaires.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06146010